February 21, 2019
Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting
Dermavant plans to initiate Phase 3 clinical program evaluating tapinarof for the treatment of psoriasis in the first half of 2019
Read Press ReleaseDermavant’s
Growing Pipeline
Dermavant is developing investigational drugs to treat atopic dermatitis, acne, hyperhidrosis and other inflammatory skin diseases and medical dermatologic conditions.
Patient-Focused
Innovation
The patient is at the heart of everything we do. It is for them that we harness scientific innovations to provide new treatment options for inflammatory skin diseases and medical dermatologic conditions with unmet medical needs.
February 21, 2019
Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting
Patient-Focused
Innovation
The patient is at the heart of everything we do. It is for them that we harness scientific innovations to provide new treatment options for inflammatory skin diseases and medical dermatologic conditions with unmet medical needs.
